Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-003681

Chief Commercial Officer sold 10,000 shares at $46.00 ($460,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weinberg Eric Chief Commercial Officer 2024-01-09 Sale 10b5-1 −10,000 $46.00 $460,000 319,978 I: show line 1 in the form
Open-market sales · 10,000 sh · avg $46.00 · $460,000
Loading xslF345X05/ownership.xml…